{"id":11007,"date":"2024-12-24T12:31:00","date_gmt":"2024-12-24T11:31:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=11007"},"modified":"2025-08-07T12:37:58","modified_gmt":"2025-08-07T10:37:58","slug":"higher-processed-blood-volume-of-granulocyte-and-monocyte-adsorption-apheresis-ameliorates-long-term-disease-activity-in-ulcerative-colitis-patients","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/es\/professional\/scientific-corner\/higher-processed-blood-volume-of-granulocyte-and-monocyte-adsorption-apheresis-ameliorates-long-term-disease-activity-in-ulcerative-colitis-patients\/","title":{"rendered":"Higher Processed Blood Volume of Granulocyte and Monocyte Adsorption Apheresis Ameliorates Long-Term Disease Activity in Ulcerative Colitis Patients"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Hamasaki+Y&amp;cauthor_id=39759489\">Yoshifumi Hamasaki<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39759489\/#full-view-affiliation-1\">1<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Matsuura+R&amp;cauthor_id=39759489\">Ryo Matsuura<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39759489\/#full-view-affiliation-2\">2<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Shinagawa+T&amp;cauthor_id=39759489\">Takahide Shinagawa<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39759489\/#full-view-affiliation-3\">3<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Ishihara+S&amp;cauthor_id=39759489\">Soichiro Ishihara<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39759489\/#full-view-affiliation-3\">3<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Ihara+S&amp;cauthor_id=39759489\">Sozaburo Ihara<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39759489\/#full-view-affiliation-4\">4<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Fujishiro+M&amp;cauthor_id=39759489\">Mitsuhiro Fujishiro<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39759489\/#full-view-affiliation-4\">4<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Doi+K&amp;cauthor_id=39759489\">Kent Doi<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39759489\/#full-view-affiliation-5\">5<\/a><\/sup>,\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?sort=date&amp;term=Nangaku+M&amp;cauthor_id=39759489\">Masaomi Nangaku<\/a><sup>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39759489\/#full-view-affiliation-1\">1<\/a>\u00a0<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39759489\/#full-view-affiliation-2\">2<\/a><\/sup><\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>J Clin Med Res. 2024 Dec;16(12):625-634.\u00a0doi: 10.14740\/jocmr6071.\u00a0Epub 2024 Dec 20.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><strong>Background:&nbsp;<\/strong>Granulocyte and monocyte adsorption apheresis (GMA) is a therapeutic option for remission induction in the active ulcerative colitis (UC) patients. Effects of high processed blood volume of GMA as remission induction therapy on the long-term prognosis of UC patients have remained unclear. For this study, we investigated the relation between re-exacerbation of UC and the processed blood volume of GMA performed as induction therapy.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><strong>Methods:&nbsp;<\/strong>Data from UC patients treated using a total of 10 GMA sessions as remission induction therapy during 2012 &#8211; 2022 were retrospectively collected and analyzed. The relation between the GMA dose, processed blood volume of GMA divided by body weight, and UC re-exacerbation requiring inpatient treatment within 1 year was evaluated.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><strong>Results:&nbsp;<\/strong>This study examined data of 72 active UC patients, with median age of 44.4 years (65% male) and median GMA dose of 34.2 mL\/kg\/session. Kaplan-Meier analysis showed the 1-year exacerbation-free rate was significantly higher in the higher GMA dose group than in the lower GMA dose group (P = 0.008). Cox proportional hazards regression analyses revealed a higher GMA dose as inversely associated with the re-exacerbation of UC within 1 year (hazard ratio: 0.36, 95% confidence interval: 0.17 &#8211; 0.78). Extended treatment time of GMA session beyond 60 min contributed to achieving the higher GMA dose and did not increase unexpected treatment termination because of clotting.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><strong>Conclusion:&nbsp;<\/strong>Greater processed blood volume of GMA per patient body weight may be associated with a lower 1-year exacerbation rate in UC patients.<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Yoshifumi Hamasaki\u00a01,\u00a0Ryo Matsuura\u00a02,\u00a0Takahide Shinagawa\u00a03,\u00a0Soichiro Ishihara\u00a03,\u00a0Sozaburo Ihara\u00a04,\u00a0Mitsuhiro Fujishiro\u00a04,\u00a0Kent Doi\u00a05,\u00a0Masaomi Nangaku\u00a01\u00a02 J Clin Med Res. 2024 Dec;16(12):625-634.\u00a0doi: 10.14740\/jocmr6071.\u00a0Epub 2024 Dec 20. Background:&nbsp;Granulocyte and monocyte adsorption apheresis (GMA) is a therapeutic option for remission induction in the active ulcerative colitis (UC) patients. Effects of high processed blood volume of GMA as remission induction therapy on the long-term prognosis [&hellip;]<\/p>\n","protected":false},"template":"","scientific_tags":[263,147,157,424,833,372,262],"class_list":["post-11007","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-bodyweight","scientific_tags-clinical-remission","scientific_tags-efficacy","scientific_tags-gma","scientific_tags-high","scientific_tags-long-term-prognosis","scientific_tags-processed-blood-volume"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Higher Processed Blood Volume of Granulocyte and Monocyte Adsorption Apheresis Ameliorates Long-Term Disease Activity in Ulcerative Colitis Patients - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/higher-processed-blood-volume-of-granulocyte-and-monocyte-adsorption-apheresis-ameliorates-long-term-disease-activity-in-ulcerative-colitis-patients\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Higher Processed Blood Volume of Granulocyte and Monocyte Adsorption Apheresis Ameliorates Long-Term Disease Activity in Ulcerative Colitis Patients - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Yoshifumi Hamasaki\u00a01,\u00a0Ryo Matsuura\u00a02,\u00a0Takahide Shinagawa\u00a03,\u00a0Soichiro Ishihara\u00a03,\u00a0Sozaburo Ihara\u00a04,\u00a0Mitsuhiro Fujishiro\u00a04,\u00a0Kent Doi\u00a05,\u00a0Masaomi Nangaku\u00a01\u00a02 J Clin Med Res. 2024 Dec;16(12):625-634.\u00a0doi: 10.14740\/jocmr6071.\u00a0Epub 2024 Dec 20. Background:&nbsp;Granulocyte and monocyte adsorption apheresis (GMA) is a therapeutic option for remission induction in the active ulcerative colitis (UC) patients. Effects of high processed blood volume of GMA as remission induction therapy on the long-term prognosis [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/higher-processed-blood-volume-of-granulocyte-and-monocyte-adsorption-apheresis-ameliorates-long-term-disease-activity-in-ulcerative-colitis-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-07T10:37:58+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/higher-processed-blood-volume-of-granulocyte-and-monocyte-adsorption-apheresis-ameliorates-long-term-disease-activity-in-ulcerative-colitis-patients\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/higher-processed-blood-volume-of-granulocyte-and-monocyte-adsorption-apheresis-ameliorates-long-term-disease-activity-in-ulcerative-colitis-patients\/\",\"name\":\"Higher Processed Blood Volume of Granulocyte and Monocyte Adsorption Apheresis Ameliorates Long-Term Disease Activity in Ulcerative Colitis Patients - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2024-12-24T11:31:00+00:00\",\"dateModified\":\"2025-08-07T10:37:58+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/higher-processed-blood-volume-of-granulocyte-and-monocyte-adsorption-apheresis-ameliorates-long-term-disease-activity-in-ulcerative-colitis-patients\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Higher Processed Blood Volume of Granulocyte and Monocyte Adsorption Apheresis Ameliorates Long-Term Disease Activity in Ulcerative Colitis Patients - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/higher-processed-blood-volume-of-granulocyte-and-monocyte-adsorption-apheresis-ameliorates-long-term-disease-activity-in-ulcerative-colitis-patients\/","og_locale":"es_ES","og_type":"article","og_title":"Higher Processed Blood Volume of Granulocyte and Monocyte Adsorption Apheresis Ameliorates Long-Term Disease Activity in Ulcerative Colitis Patients - Adacyte","og_description":"Yoshifumi Hamasaki\u00a01,\u00a0Ryo Matsuura\u00a02,\u00a0Takahide Shinagawa\u00a03,\u00a0Soichiro Ishihara\u00a03,\u00a0Sozaburo Ihara\u00a04,\u00a0Mitsuhiro Fujishiro\u00a04,\u00a0Kent Doi\u00a05,\u00a0Masaomi Nangaku\u00a01\u00a02 J Clin Med Res. 2024 Dec;16(12):625-634.\u00a0doi: 10.14740\/jocmr6071.\u00a0Epub 2024 Dec 20. Background:&nbsp;Granulocyte and monocyte adsorption apheresis (GMA) is a therapeutic option for remission induction in the active ulcerative colitis (UC) patients. Effects of high processed blood volume of GMA as remission induction therapy on the long-term prognosis [&hellip;]","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/higher-processed-blood-volume-of-granulocyte-and-monocyte-adsorption-apheresis-ameliorates-long-term-disease-activity-in-ulcerative-colitis-patients\/","og_site_name":"Adacyte","article_modified_time":"2025-08-07T10:37:58+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/higher-processed-blood-volume-of-granulocyte-and-monocyte-adsorption-apheresis-ameliorates-long-term-disease-activity-in-ulcerative-colitis-patients\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/higher-processed-blood-volume-of-granulocyte-and-monocyte-adsorption-apheresis-ameliorates-long-term-disease-activity-in-ulcerative-colitis-patients\/","name":"Higher Processed Blood Volume of Granulocyte and Monocyte Adsorption Apheresis Ameliorates Long-Term Disease Activity in Ulcerative Colitis Patients - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2024-12-24T11:31:00+00:00","dateModified":"2025-08-07T10:37:58+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/higher-processed-blood-volume-of-granulocyte-and-monocyte-adsorption-apheresis-ameliorates-long-term-disease-activity-in-ulcerative-colitis-patients\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner\/11007","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=11007"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific_tags?post=11007"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}